Show simple item record

dc.contributor.authorBaylis, Richard Aen
dc.contributor.authorGomez, Delphineen
dc.contributor.authorMallat, Ziaden
dc.contributor.authorPasterkamp, Gerarden
dc.contributor.authorOwens, Gary Ken
dc.date.accessioned2019-03-19T09:35:04Z
dc.date.available2019-03-19T09:35:04Z
dc.date.issued2017-11en
dc.identifier.issn1079-5642
dc.identifier.urihttps://www.repository.cam.ac.uk/handle/1810/290632
dc.format.mediumPrint-Electronicen
dc.languageengen
dc.subjectHumansen
dc.subjectAnti-Inflammatory Agentsen
dc.subjectAntibodies, Monoclonalen
dc.subjectTreatment Outcomeen
dc.subjectCardiologyen
dc.subjectAtherosclerosisen
dc.subjectCoronary Artery Diseaseen
dc.subjectRandomized Controlled Trials as Topicen
dc.subjectClinical Trials, Phase III as Topicen
dc.subjectAntibodies, Monoclonal, Humanizeden
dc.titleThe CANTOS Trial: One Important Step for Clinical Cardiology but a Giant Leap for Vascular Biology.en
dc.typeArticle
prism.endingPagee177
prism.issueIdentifier11en
prism.publicationDate2017en
prism.publicationNameArteriosclerosis, thrombosis, and vascular biologyen
prism.startingPagee174
prism.volume37en
dc.identifier.doi10.17863/CAM.24596
rioxxterms.versionofrecord10.1161/atvbaha.117.310097en
rioxxterms.versionAM*
rioxxterms.licenseref.urihttp://www.rioxx.net/licenses/all-rights-reserveden
rioxxterms.licenseref.startdate2017-11en
dc.contributor.orcidGomez, Delphine [0000-0002-3880-6961]
dc.contributor.orcidMallat, Ziad [0000-0003-0443-7878]
dc.identifier.eissn1524-4636
rioxxterms.typeJournal Article/Reviewen
pubs.funder-project-idBritish Heart Foundation (RG/15/11/31593)


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record